Patent US1968075A successfully refreshed from Google Patents.
Patent US5578073A successfully refreshed from Google Patents.
US5578073A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Thromboresistant surface treatment for biomaterials
Assignee: Ramot at Tel Aviv University Ltd
•
Filing: 1994-09-16
•
Granted: 1996-11-26
•
Expires: 2014-09-16
Abstract
Abstract A biomaterial with a thromboresistant surface and a method for forming same are provided. The thromboresistant surface is comprised of a distinct coating layer of a chitosan-based membrane and a biologically active material. The biologically active material is capable of converting the chitosan membrane coating from a highly thrombogenic to an essentially non-thrombogenic one. The biologically active material can be a polymeric substance, such as polyvinyl alcohol, forming a polymeric blend with the chitosan, or, can be a biological substance, such as serum albumin, embedded in or attached to the chitosan membrane which has been activated with a treatment of glutardialdehyde. The thromboresistant biomaterial is suitable for use in vascular grafts having an inside diameter of less than 6 millimeters.
Inventors
- 👤 Beatrice Haimovich
- 👤 Amihay Freeman
- 👤 Ralph Greco
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 17:30
CPC Classifications
C; C09; C09D; C09D105/00; C09D105/08; A; A61; A61F; A61F2/00; A61F2/02; A61F2/04; A61F2/06; A61F2/24; A61L; A61L33/00; A61L33/06; A61L33/062
Claims Analysis
Total Claims: 23
Claim 1
Independent Claim
61 words
A biomedical device or prosthesis having a blood contacting surface which has improved antithrombogenic properties and improved strength, which device or prosthesis has a coating which comprises a blend of chitosan and polyvinyl alcohol wherein the biomedical is a homopolymer or a copolymer selected from the group consisting of polytetrafluoroethylenes, polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals.
Claim 2
Dependent Claim
61 words
A biomedical device or prosthesis having a blood contacting surface which has improved antithrombogenic properties and improved strength, which device or prosthesis has a coating which comprises a blend of chitosan and polyvinyl alcohol wherein the biomedical is a homopolymer or a copolymer selected from the group consisting of polytetrafluoroethylenes, polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals.
Claim 3
Dependent Claim
16 words
The biomedical device or prosthesis of claim 1 wherein a portion of the device is tubular.
Claim 4
Dependent Claim
17 words
The biomedical device or prosthesis of claim 2 wherein the interior diameter is less than 4 mm.
Claim 5
Dependent Claim
36 words
The biomedical device or prosthesis of claim 1 which is selected from the group consisting of catheters, vascular grafts, cardiac pacemakers, pacemaker leads, heart diaphragms, heart valves, sutures, needles, angioplasty devices, tubing, filters, and dialysis membranes.
Claim 6
Dependent Claim
66 words
A biomaterial which has improved antithrombogenic properties and improved strength, which biomaterial has a coating which comprises a blend of chitosan and polyvinyl alcohol wherein the biomaterial is a homopolymer or a copolymer selected from the group consisting of polytetrafluoroethylenes, polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals, which biomaterial is for use in a device or prosthesis having a blood contacting surface.
Claim 7
Dependent Claim
66 words
A biomaterial which has improved antithrombogenic properties and improved strength, which biomaterial has a coating which comprises a blend of chitosan and polyvinyl alcohol wherein the biomaterial is a homopolymer or a copolymer selected from the group consisting of polytetrafluoroethylenes, polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals, which biomaterial is for use in a device or prosthesis having a blood contacting surface.
Claim 8
Dependent Claim
9 words
The biomaterial of claim 5 which is a metal.
Claim 9
Dependent Claim
37 words
A biomaterial which has improved antithrombogenic properties and which has a coating which comprises chitosan and as a biologically active material which active material is attached to the chitosan at glutaraldehyde-activated free amino sites, human serum albumin.
Claim 10
Dependent Claim
37 words
A biomaterial which has improved antithrombogenic properties and which has a coating which comprises chitosan and as a biologically active material which active material is attached to the chitosan at glutaraldehyde-activated free amino sites, human serum albumin.
Claim 11
Dependent Claim
30 words
The biomaterial of claim 7 which is a homopolymer or a copolymer selected from the group consisting of polytetrafluoroethylenes, polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals.
Claim 12
Dependent Claim
89 words
A process for treating a biomaterial for use in a biomedical device or prosthesis which has a blood contacting surface, which has improved antithrombogenic properties and improved strength, comprising contacting the surface of the biomaterial with a mixture of a solution of chitosan and polyvinyl alcohol, removing any excess solution, and curing the remaining solution on the surface, thereby obtaining the improved coating, the biomaterial being a homopolymer or a copolymer selected from the group consisting of polytetrafluoroethylenes, polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals.
Claim 13
Dependent Claim
89 words
A process for treating a biomaterial for use in a biomedical device or prosthesis which has a blood contacting surface, which has improved antithrombogenic properties and improved strength, comprising contacting the surface of the biomaterial with a mixture of a solution of chitosan and polyvinyl alcohol, removing any excess solution, and curing the remaining solution on the surface, thereby obtaining the improved coating, the biomaterial being a homopolymer or a copolymer selected from the group consisting of polytetrafluoroethylenes, polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals.
Claim 14
Dependent Claim
24 words
The process of claim 9 wherein a portion of the biomedical device or prosthesis is tubular with an interior diameter less than 6 mm.
Claim 15
Dependent Claim
106 words
A process for treating a biomaterial for use in a biomedical device or prosthesis which has a blood contacting surface and improved antithrombotic properties, comprising contacting the surface of the biomaterial with a chitosan solution, and activating free amino groups on the chitosan by treating the chitosan on the surface of the biomaterial with a solution of glutaraldehyde, wherein the biomaterial is a homopolymer or a copolymer selected from the group consisting of polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals and treating the activated chitosan with a biologically active material selected from the group consisting of surfactants, antithrombotic agents, antibiotics, and antibodies.
Claim 16
Dependent Claim
106 words
A process for treating a biomaterial for use in a biomedical device or prosthesis which has a blood contacting surface and improved antithrombotic properties, comprising contacting the surface of the biomaterial with a chitosan solution, and activating free amino groups on the chitosan by treating the chitosan on the surface of the biomaterial with a solution of glutaraldehyde, wherein the biomaterial is a homopolymer or a copolymer selected from the group consisting of polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals and treating the activated chitosan with a biologically active material selected from the group consisting of surfactants, antithrombotic agents, antibiotics, and antibodies.
Claim 17
Dependent Claim
14 words
The process of claim 11 wherein the biologically active material is human serum albumin.
Claim 18
Dependent Claim
24 words
The process of claim 11 wherein a portion of the biomedical device or prosthesis is tubular with an interior diameter less than 6 mm.
Claim 19
Dependent Claim
57 words
A polymeric or metal biomedical device or prosthesis having a blood contacting surface which has improved antithrombogenic properties and improved strength, which device or prosthesis has a coating which comprises a blend of chitosan and polyvinyl alcohol, wherein the device or prosthesis has a portion which is tubular of an interior diameter of less than 6 mm.
Claim 20
Dependent Claim
57 words
A polymeric or metal biomedical device or prosthesis having a blood contacting surface which has improved antithrombogenic properties and improved strength, which device or prosthesis has a coating which comprises a blend of chitosan and polyvinyl alcohol, wherein the device or prosthesis has a portion which is tubular of an interior diameter of less than 6 mm.
Claim 21
Dependent Claim
20 words
The device or prosthesis of claim 14 wherein the interior diameter of the tubular portion is less than 4 mm.
Claim 22
Dependent Claim
35 words
The device or prosthesis of claim 14 which is selected from the group consisting of catheters, vascular grafts, cardiac pacemakers, pacemaker leads, heart diaphragms, heart valves, sutures, needles, angioplasty devices, tubing, filters, and dialysis membranes.
Claim 23
Dependent Claim
11 words
The device or prosthesis of claim 14 which is a graft.
References Cited (Backward Citations)
US3962158A
Cited
US4321711A
Cited
US4326532A
Cited
US4311573A
Cited
US4787900A
Cited
US5197977A
Cited
EP0230635A2
Cited
US5028597A
Cited
US5263992A
Cited
US5053048A
Cited
US4978481A
Cited
JPH03109930A
Cited
US5346935A
Cited
JPH059393A
Cited
JPH05168878A
Cited
US5420197A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-11-26 | 2000-05-27 | 2000-11-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-11-26 | 2004-05-27 | 2004-11-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-11-26 | 2008-05-27 | 2008-11-26 | $7700.00 | Window Closed / Lapsed |